HAEMATO AG (XTER:HAEK) Price-to-Operating-Cash-Flow : 9.87 (As of May. 13, 2024)

View and export this data going back to 2005. Start your Free Trial

What is HAEMATO AG Price-to-Operating-Cash-Flow?

As of today (2024-05-13), HAEMATO AG's share price is €21.40. HAEMATO AG's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was €2.17. Hence, HAEMATO AG's Price-to-Operating-Cash-Flow Ratio for today is 9.87.

The historical rank and industry rank for HAEMATO AG's Price-to-Operating-Cash-Flow or its related term are showing as below:

XTER:HAEK' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 3.26 Med: 10.85 Max: 216.87
Current: 6.94

During the past 13 years, HAEMATO AG's highest Price-to-Operating-Cash-Flow Ratio was 216.87. The lowest was 3.26. And the median was 10.85.

XTER:HAEK's Price-to-Operating-Cash-Flow is ranked better than
84.32% of 676 companies
in the Drug Manufacturers industry
Industry Median: 17.545 vs XTER:HAEK: 6.94

HAEMATO AG's Cash Flow from Operations per share for the six months ended in Jun. 2023 was €0.21. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was €2.17.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of HAEMATO AG was -53.10% per year.

During the past 13 years, HAEMATO AG's highest 3-Year average Operating Cash Flow per Share Growth Rate was 122.90% per year. The lowest was -56.50% per year. And the median was 13.50% per year.

HAEMATO AG Price-to-Operating-Cash-Flow Historical Data

The historical data trend for HAEMATO AG's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HAEMATO AG Price-to-Operating-Cash-Flow Chart

HAEMATO AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

188.35

3.65

8.41

4.31

HAEMATO AG Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	8.41	-	4.31	-

Competitive Comparison of HAEMATO AG's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, HAEMATO AG's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HAEMATO AG's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HAEMATO AG's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where HAEMATO AG's Price-to-Operating-Cash-Flow falls into.

HAEMATO AG Price-to-Operating-Cash-Flow Calculation

HAEMATO AG's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	21.40	/	2.169
	=	9.87

HAEMATO AG's Share Price of today is €21.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. HAEMATO AG's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was €2.17.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

HAEMATO AG Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of HAEMATO AG's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

HAEMATO AG (XTER:HAEK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HAEMATO AG (XTER:HAEK) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

HAEK:Germany HAEK:Germany HAEK:Germany

Address

Lilienthalstrasse 5c, Schonefeld, DEU, D-12529

Website

https://www.haemato.ag

HAEMATO AG is a Germany based pharmaceutical company. It provides pharmaceuticals for the care of chronically ill people. The firm is engaged in the sale of generic and EU (European countries) import drugs. It is focused on patented and non-patented medicinal products. The company product portfolio includes human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), neurology, oncology, rheumatology, and urology. Geographically, it operates only in Germany.

HAEMATO AG (XTER:HAEK) Headlines

No Headlines